[Federal Register: July 20, 2006 (Volume 71, Number 139)]
[Notices]
[Page 41283-41287]
[DOCID:fr20jy06-93]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-54137; File No. SR-Amex-2006-67]

Self-Regulatory Organizations; American Stock Exchange LLC;
Notice of Filing and Immediate Effectiveness of Proposed Rule Change To
Permit the Listing and Trading of Quarterly Options Series

July 12, 2006.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on July 11, 2006, the American Stock Exchange LLC (``Exchange'' or
``Amex'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II below, which Items have been substantially prepared by the Exchange.
The Exchange has designated this proposal as non-controversial under
Section 19(b)(3)(A)(iii) of the Act \3\ and Rule 19b-4(f)(6)
thereunder,\4\ which renders the proposed rule change effective upon
filing with the Commission. The Commission is publishing this notice to
solicit comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \4\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend its rules to permit the listing and
trading of quarterly options series.\5\ The text of the proposed rule
change is set forth below. Proposed new language is in italics;
language proposed to be deleted is in [brackets].
---------------------------------------------------------------------------

    \5\ This proposal is substantially identical to a recently
approved proposal by the International Securities Exchange (``ISE'')
to list Quarterly Options Series on a pilot basis. See Securities
Exchange Act Releases No. 53857 (May 24, 2006), 71 FR 31246 (June 1,
2006) (notice of filing); and 54113 (July 7, 2006) (approval order).
---------------------------------------------------------------------------

* * * * *

Rule 900--Applicability, Definitions and References

    (a) No change.
    (b) Definitions--The following terms as used in the Rules in this
Chapter shall, unless the context otherwise indicates, have the
meanings herein specified:
    (1)-(44) No change.
    (45) Quarterly Options Series--The term ``Quarterly Options
Series'' means a series in an options class that is approved for
listing and trading on the Exchange in which the series is opened for
trading on any business day and that expires at the close of business
on the last business day of a calendar quarter:
    (c)-(d) No change.
* * * Commentary
    .01 No change.
* * * * *

Rule 903--Series of Options Open for Trading

    (a) After a particular class of options (call option contracts or
put option contracts relating to a specific underlying security or
calculated index) has been approved for listing and trading on the
Exchange, the Exchange shall from time to time open for trading series
of options therein. Prior to the opening of trading in any series of
options, the Exchange shall fix the expiration month, expiration year
(if the options series has more than one year remaining to expiration),
and exercise price of option contracts included in each such series.
For Short Term Options Series, the Exchange will fix a specific
expiration date and exercise price, as provided in paragraph (h). For
Quarterly Options Series, the Exchange will fix a specific expiration
date and exercise price, as provided in Commentary .09.
    (b)-(h) No change.

* * * Commentary
    .01-.08 No change.
    .09 Quarterly Options Series Pilot Program: For a pilot period, the
Exchange may list and trade options series that expire at the close of
business on the last business day of a calendar quarter (``Quarterly
Options Series''). The Exchange may list Quarterly Options Series for
up to five (5) currently listed options classes that are either Stock
Index Options or options on exchange traded funds. In addition, the
Exchange may also list Quarterly Options Series on any options classes
that are selected by other securities exchanges that employ a similar
pilot program under their respective rules. The pilot will commence the
day the Exchange first initiates trading in a Quarterly Options Series,
which shall be no later than August 10, 2006 and will expire on July
10, 2007.
    (a) The Exchange will list series that expire at the end of the
next consecutive four (4) calendar quarters, as well as the fourth
quarter of the next calendar year. For example, if the Exchange is
trading Quarterly Options Series in the month of May 2006, it will list
series that expire at the end of the second, third and fourth quarters
of 2006, as well as the first and fourth quarters of 2007. Following
the second quarter 2006 expiration, the Exchange will add series that
expire at the end of the second quarter of 2007.
    (b) The Exchange will not list a Short Term Options Series on an
options class whose expiration coincides with that of a Quarterly
Options Series on that same options class.
    (c) The strike price of each Quarterly Options Series will be fixed
at a price per share, with at least two strike prices above and two
strike prices below the value of the underlying security at about the
time that a Quarterly Options Series is opened for trading on the
Exchange. The Exchange shall list strike prices for a Quarterly Options
Series that are within $5 from the closing price of the underlying on
the preceding day. Additional Quarterly Options Series of the same
class may be opened for trading on the Exchange when the Exchange deems
it necessary to maintain an orderly market, to meet customer demand or
when the market price of the underlying security moves substantially
from the initial exercise price or prices. To the extent that any
additional strike prices are listed by the Exchange, such additional
strike prices shall be within $5 from the closing price of the
underlying on the preceding day. The opening of new Quarterly Options
Series shall not affect the series of options of the same class
previously opened.
    (d) The interval between strike prices on Quarterly Options Series
shall be the same as the interval for strike prices for series in that
same options class that expire in accordance with the normal monthly
expiration cycle.
* * * * *

Rule 900C--Applicability and Definitions

    (a) No change.
    (b) Definitions--The following terms as used in the Rules in this
Section shall, unless the context otherwise indicates, have the
meanings herein specified:
    (1)-(25) No change.
    (26) Quarterly [Index Expiration] Options Series--The term
``quarterly [index expiration] options series'' means [an option
contract on a stock index group that expires on the first business day
of the month following the end of a calendar quarter], for the purposes
of this Section 14, a series in an index options class that is approved
for listing and trading on the Exchange in which the series is opened
for trading on any business day and that expires at the close of
business on the last business day of a calendar quarter.
    (27) No change.
* * * * *

Rule 903C--Series of Stock Index Options

    (a) No change.
    (i)-(iii) No change.
    (iv) [Quarterly Index Expiration Option Series--The Exchange may
list options on the Major Market (``XMI''), Institutional (``XII'') and
S&P MidCap 400 (``MID'') stock indices that expire on the first
business day of the month following the end of a calendar quarter. For
such options, the Exchange may list up to eight consecutive quarterly
expirations with an index multiplier no greater than 500. All other
contract terms for such options will conform to the terms of the XMI,
XII and MID options listed pursuant to the provisions of Rule
903C(a)(i) and (ii) above.] Quarterly Options Series Pilot Program: For
a pilot period, the Exchange may list and trade options series that
expire at the close of business on the last business day of a calendar
quarter (``Quarterly Options Series''). The Exchange may list Quarterly
Options Series for up to five (5) currently listed options classes that
are either Stock Index Options or options on exchange traded funds. In
addition, the Exchange may also list Quarterly Options Series on any
options classes that are selected by other securities exchanges that
employ a similar pilot program under their respective rules. The pilot
will commence the day the Exchange first initiates trading in a
Quarterly Options Series, which shall be no later than August 10, 2006
and will expire on July 10, 2007.
    1. The Exchange will list series that expire at the end of the next
consecutive four (4) calendar quarters, as well as the fourth quarter
of the next calendar year. For example if the Exchange is trading
Quarterly Options Series in the month of May 2006, it will list series
that expire at the end of the second, third and fourth quarters of
2006, as well as the first and fourth quarters of 2007. Following the
second quarter 2006 expiration, the Exchange will add series that
expire at the end of the second quarter of 2007.
    2. The Exchange will not list a Short Term Option Series on an
options class whose expiration coincides with that of a Quarterly
Options Series on that same options class.
    3. Quarterly Options Series shall be P.M. settled.
    4. The strike price of each Quarterly Options Series will be fixed
at a price per share, with at least two strike prices above and two
strike prices below the value of the underlying security at about the
time that a Quarterly Options Series is opened for trading on the
Exchange. The Exchange shall list strike prices for a Quarterly Options
Series that are within $5 from the closing price of the underlying on
the preceding day. The Exchange may open for trading additional
Quarterly Options Series of the same class if the current index value
of the underlying index moves substantially from the exercise price of
those Quarterly Options Series that already have been opened for
trading on the Exchange. The exercise price of each Quarterly Options
Series opened for trading on the Exchange shall be reasonably related
to the current index value of the underlying index to which such series
relates at or about the time such series of options is first opened for
trading on the Exchange. The term ``reasonably related to the current
index value of the underlying index'' means that the exercise price is
within thirty percent (30%) of the current index value. The Exchange
may also open for trading additional Quarterly Options Series that are
more than thirty percent (30%) away from the current index value,
provided that demonstrated customer interest exists for such series, as
expressed by institutional, corporate, or individual customers or their
brokers. Market-makers trading for their own account shall not be
considered when

determining customer interest under this provision.
    5. The interval between strike prices on Quarterly Options Series
shall be the same as the interval for strike prices for series in that
same options class that expire in accordance with the normal monthly
expiration cycle.
    (v) No change.
    (b)-(c) No change.
* * * Commentary
    .01-.04 No change.

Rule 904C--Position Limits

    (a) No change.
    (b) Broad Stock Index Groups. No change.

--Full Size Nasdaq 100 Index Options (NDX) through Eurotop 100 Index
Options--No change.
--Positions in Short Term Option Series and Quarterly Options Series
shall be aggregated with positions in options contracts on the same
index.
--Russell 1000 Index Options, etc.--No change.

    (c) Stock Index Industry Groups.
    (i) Subject to the procedures specified in sub-paragraph (iii) of
this paragraph (c), the Exchange shall establish a position limit with
respect to options on the Pauze[eacute] Tombstone Common Stock Index of
6,000 contracts and for each underlying stock index industry group at a
level no greater than:

--18,000 contracts if the Exchange determines, at the time of a review
conducted pursuant to subparagraph (ii) of this paragraph (c), that any
single stock in the group accounted, on average, for 30% or more of the
numerical index value during the 30-day period immediately preceding
the review; or
--24,000 contracts if the Exchange determines, at the time of a review
conducted pursuant to subparagraph (ii) of this paragraph (c), that any
single stock in the group accounted, on average, for 20% or more of the
numerical index value or that any five stocks in the group together
accounted, on average, for more than 50% of the numerical index value,
but that no single stock in the group accounted, on average, for 30% or
more of the numerical index value, during the 30-day period immediately
preceding the review; or
--31,500 contracts if the Exchange determines that the conditions
specified above which would require the establishment of a lower limit
have not occurred.
--Positions in Short Terms Option Series and Quarterly Options Series
shall be aggregated with positions in options contracts on the same
index.

    (ii)-(iii) No change.
    (d) No change.
* * * * *

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of, and basis for, the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to amend its rules to accommodate the listing
of options series that would expire at the close of business on the
last business day of a calendar quarter (``Quarterly Options
Series'').\6\ Quarterly Options Series could be opened on any approved
options class \7\ on a business day (``Quarterly Options Opening
Date'') and would expire at the close of business on the last business
day of a calendar quarter (``Quarterly Options Expiration Date''). The
Exchange would list series that expire at the end of the next four
consecutive calendar quarters, as well as the fourth quarter of the
next calendar year. For example, if the Exchange were trading Quarterly
Options Series in the month of May 2006, it would list series that
expire at the end of the second, third, and fourth quarters of 2006, as
well as the first and fourth quarters of 2007. Following the second
quarter 2006 expiration, the Exchange would add series that expire at
the end of the second quarter of 2007.
---------------------------------------------------------------------------

    \6\ In 1993, the Exchange was granted SEC approval to list and
trade broad-based index options that expire at the end of each
quarter. See Securities Exchange Act Release No. 31844 (February 9,
1993); 58 FR 8796 (February 17, 1993). The Exchange listed and
traded these options on the Major Market Index (XMI), Institutional
Index (XII) and S&P Midcap Index (MID). These quarterly-style
options proved to be of limited use to investors and did not trade
particularly well, largely because they were A.M.-settled options.
    \7\ Quarterly Options Series may be opened in options on indexes
or options on Exchange Traded Fund (``ETFs'') that satisfy the
applicable listing criteria under Amex rules.
---------------------------------------------------------------------------

    Quarterly Options Series listed on currently approved options
classes would be P.M.-settled and, in all other respects, would settle
in the same manner as do the monthly expiration series in the same
options class.
    The proposed rule change would allow the Exchange to open up to
five currently listed options classes that are either index options or
options on ETFs. The strike price for each series would be fixed at a
price per share, with at least two strike prices above and two strike
prices below the approximate value of the underlying security at about
the time that a Quarterly Options Series is opened for trading on the
Exchange. The Exchange may list strike prices for a Quarterly Options
Series that are within $5 from the closing price of the underlying
security on the preceding trading day. The proposal would permit the
Exchange to open for trading additional Quarterly Options Series of the
same class when the Exchange deems it necessary to maintain an orderly
market, to meet customer demand, or when the current market price of
the underlying security moves substantially from the exercise prices of
those Quarterly Options Series that already have been opened for
trading on the Exchange. In addition, the exercise price of each
Quarterly Options Series on an underlying index would be required to be
reasonably related to the current index value of the index at or about
the time such series of options were first opened for trading on the
Exchange. The term ``reasonably related to the current index value of
the underlying index'' means that the exercise price is within thirty
percent of the current index value. The Exchange would also be
permitted to open for trading additional Quarterly Options Series on an
underlying index that are more than thirty percent away from the
current index value, provided that demonstrated customer interest
exists for such series, as expressed by institutional, corporate, or
individual customers or their brokers. Market-Makers trading for their
own account shall not be considered when determining customer interest
under this provision.
    Because monthly options series expire on the third Friday of their
expiration month, a Quarterly Options Series, which would expire on the
last business day of the quarter, could never expire in the same week
in which a monthly options series in the same class expires. The same,
however, is not the case for Short Term Option Series. Quarterly
Options Series and Short Term Option Series on the same options class
could potentially expire concurrently under

the proposal.\8\ Therefore, to avoid any confusion in the marketplace,
the proposal stipulates that the Exchange may not list a Short Term
Option Series that expires at the end of the day on the same day as a
Quarterly Options Series in the same class expires. In other words, the
proposed rules would not permit the Exchange to list a P.M.-settled
Short Term Option Series on an ETF or an index that would expire on a
Friday that is the last business day of a calendar quarter if a
Quarterly Options Series on that ETF or index were scheduled to expire
on that day.
---------------------------------------------------------------------------

    \8\ The Exchange currently does not have any Short Term Option
Series listed for trading.
---------------------------------------------------------------------------

    However, the proposed rules would permit the Exchange to list as
A.M.-settled Short Term Option Series and a P.M.-settled Quarterly
Options Series in the same options class that both expire on the same
day (i.e., on a Friday that is the last business day of the calendar
quarter). The Exchange believes that the concurrent listing of an A.M.-
settled Short Term Option Series and a P.M.-settled Quarterly Options
Series on the same underlying ETF or index that expire on the same day
would not tend to cause the same confusion as would P.M.-settled short
term and quarterly series in the same options class, and would provide
investors with an additional hedging mechanism.
    Finally, the interval between strike prices on Quarterly Options
Series would be the same as the interval for strike prices for series
in the same options class that expires in accordance with the normal
monthly expiration cycles.
    The Exchange believes that Quarterly Options Series would provide
investors with a flexible and valuable tool to manage risk exposure,
minimize capital outlays, and be more responsive to the timing of
events affecting the securities that underlie option contracts. At the
same time, the Exchange is cognizant of the need to be cautious in
introducing a product that can increase the number of outstanding
strike prices. For that reason, the Exchange intends to employ a
limited pilot program (``Pilot Program'') for Quarterly Options Series.
Under the terms of the Pilot Program, the Exchange could select up to
five option classes on which Quarterly Options Series may be opened on
any Quarterly Options Opening Date. The Exchange would also be allowed
to list those Quarterly Options Series on any options class that is
selected by another securities exchange with a similar Pilot Program
under its rules. The Exchange believes that limiting the number of
options classes in which Quarterly Options Series may be opened would
help to ensure that the addition of the new series through this Pilot
Program will have only a negligible impact on the Exchange's and the
Option Price Reporting Authority's (``OPRA'') quoting capacity. Also,
limiting the term of the Pilot Program to a period of approximately one
year will allow the Exchange and the Commission to determine whether
the program should be extended, expanded, and/or made permanent.
    If the Exchange were to propose an extension or an expansion of the
program, or were the Exchange to propose to make the Pilot Program
permanent, the Exchange would submit, along with any filing proposing
such amendments to the Pilot Program, a Pilot Program report
(``Report'') that will provide an analysis of the Pilot Program
covering the entire period during which the Pilot Program was in
effect. The Report would include, at a minimum: (1) Data and written
analysis on the open interest and trading volume in the classes for
which Quarterly Option Series were opened; (2) an assessment of the
appropriateness of the options classes selected for the Pilot Program;
(3) an assessment of the impact of the Pilot Program on the capacity of
the Amex, OPRA, and on market data vendors (to the extent data from
market data vendors is available); (4) any capacity problems or other
problems that arose during the operation of the Pilot Program and how
the Amex addressed such problems; (5) any complaints that the Amex
received during the operation of the Pilot Program and how the Amex
addressed them; and (6) any additional information that would assist in
assessing the operation of the Pilot Program. The Report must be
submitted to the Commission at least sixty days prior to the expiration
date of the Pilot Program.
    Alternatively, at the end of the Pilot Program, if the Exchange
determines not to propose an extension or an expansion of the Pilot
Program, or if the Commission determines not to extend or expand the
Pilot Program, the Exchange would no longer list any additional
Quarterly Options Series and would limit all existing open interest in
Quarterly Options Series to closing transactions only.
    Finally, the Exchange represents that it has the necessary systems
capacity to support new options series that will result from the
introduction of Quarterly Options Series.
2. Statutory Basis
    The Exchange believes that the introduction of Quarterly Options
Series will satisfy institutional demand for such options and provide
additional flexibility and additional risk management tools to
investors. For these reasons, the Exchange believes that the proposed
rule change is consistent with Section 6(b) of the Act \9\ in general
and furthers the objectives of Section 6(b)(5) of the Act \10\ in
particular in that it is designed to promote just and equitable
principles of trade, to prevent fraudulent and manipulative acts and
practices, and, in general, to protect investors and the public
interest.
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78f(b).
    \10\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The Exchange has filed the proposed rule change pursuant to Section
19(b)(3)(A) of the Act \11\ and subparagraph (f)(6) of Rule 19b-4
thereunder.\12\ Because the foregoing proposed rule change (i) Does not
significantly affect the protection of investors or the public
interest; (ii) does not impose any significant burden on competition;
and (iii) does not become operative for 30 days from the date on which
it was filed, or such shorter time as the Commission may designate, if
consistent with the protection of investors and the public interest,
the proposed rule change has become effective pursuant to Section
19(b)(3)(A) of the Act and Rule 19b-4(f)(6)(iii) thereunder.\13\
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78s(b)(3)(A).
    \12\ 17 CFR 240.19b-4(f)(6).
    \13\ Rule 19b-4(f)(6)(iii) requires the Exchange to give written
notice to the Commission of its intent to file the proposed rule
change five business days prior to filing. The Commission has
determined to waive the five-day pre-filing requirement for this
proposal.
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) normally does
not become operative for 30 days after the

date of filing. However, Rule 19b-4(f)(6)(iii) permits the Commission
to waive the operative delay if such action is consistent with the
protection of investors and the public interest. The Exchange has asked
the Commission to waive the operative delay to permit the Pilot Program
extension to become effective prior to the 30th day after filing.
    The Commission believes that waiving the 30-day operative delay is
consistent with the protection of investors and the public interest.
The Commission notes that the proposal is substantially identical to
the ISE's Quarterly Option Series Pilot Program, previously published
for comment and approved by the Commission,\14\ and thus the Exchange's
proposal raises no new issues of regulatory concern. Moreover, waiving
the operative delay will allow the Exchange to immediately compete with
other exchanges that list and trade quarterly options under similar
programs, and consequently will benefit the public. Therefore, the
Commission has determined to waive the 30-day delay and allow the
proposed rule change to become operative immediately.\15\
---------------------------------------------------------------------------

    \14\ See supra note 5.
    \15\ For purposes only of waiving the operative delay of this
proposal, the Commission notes that it has considered the proposed
rule's impact on efficiency, competition, and capital formation. 15
U.S.C. 78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission may summarily abrogate such rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
); or     Send an e-mail to<EMAIL_ADDRESS>Please include

File No. SR-Amex-2006-67 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-Amex-2006-67. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commissions Internet Web site (http://www.sec.gov/rules/sro.shtml).

Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for inspection and copying in the
Commission's Public Reference Room. Copies of such filing also will be
available for inspection and copying at the principal office of the
Exchange. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
Amex-2006-67 and should be submitted on or before August 10, 2006.
---------------------------------------------------------------------------

    \16\ 17 CFR 200.30-3(a)(12).

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\16\
J. Lynn Taylor,
Assistant Secretary.
 [FR Doc. E6-11489 Filed 7-19-06; 8:45 am]

BILLING CODE 8010-01-P


[Federal Register: April 22, 2009 (Volume 74, Number 76)]
[Notices]
[Page 18370]
[DOCID:fr22ap09-38]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket Nos. CP09-110-000;CP07-4-002]

Mississippi Hub, LLC; Notice of Filing

April 15, 2009.
    On April 7, 2009, Mississippi Hub, LLC (MS Hub), pursuant to
section 7(c) of the Natural Gas Act (NGA), for authorization to expand
the MS HUB Gas Storage Project (Expansion) previously certificated in
CP07-4-000, et al. on February 15, 2007, as amended, in Covington,
Jefferson Davis, and Simpson Counties, Mississippi. MS Hub proposes to
increase the total capacity of each of its two authorized caverns by
2.38 Billion cubic feet (Bcf) (1.5 Bcf working gas and 0.88 Bcf cushion
gas); increase the maximum injection and withdrawal rate of the storage
facility; add four 7,700 horsepower (hp) compressor units in lieu of
three 5,000 hp compressor units previously authorized; and, construct
14.2 miles of 24-inch diameter pipeline and 22.6 miles of 30-inch
diameter pipeline interconnects. MS Hub requests a finding that after
the Expansion, the storage project's operation will not exercise market
power so that market-based rates may continue to be charged for these
services.
    Questions concerning this application may be directed to William
Rapp, Liberty Gas Storage, 101 Ash Street, San Diego, CA 92101, at
(619) 699-5050.
    On September 15, 2008, the Commission staff granted MS Hub's
request to utilize the Pre-filing Process and assigned Docket No. PF08-
29-000 to staff activities involving the Expansion. Now, as of the
filing of this application on April 7, 2009, the Pre-filing Process for
this project has ended. From this time forward, these proceedings will
be conducted in the Dockets noted in the caption to this Notice.
    Pursuant to section 157.9 of the Commission's rules, 18 CFR 157.9,
within 90 days of this Notice the Commission staff will either:
Complete its environmental assessment (EA) and place it into the
Commission's public record (eLibrary) for this proceeding; or issue a
Notice of Schedule for Environmental Review. If a Notice of Schedule
for Environmental Review is issued, it will indicate, among other
milestones, the anticipated date for the Commission staff's issuance of
the final environmental impact statement (FEIS) or EA for this
proposal. The filing of the EA in the Commission's public record for
this proceeding or the issuance of a Notice of Schedule for
Environmental Review will serve to notify federal and state agencies of
the timing for the completion of all necessary reviews, and the
subsequent need to complete all federal authorizations within 90 days
of the date of issuance of the Commission staff's FEIS or EA.
    There are two ways to become involved in the Commission's review of
this project. First, any person wishing to obtain legal status by
becoming a party to the proceedings for this project should, on or
before the comment date stated below, file with the Federal Energy
Regulatory Commission, 888 First Street, NE., Washington, DC 20426, a
motion to intervene in accordance with the requirements of the
Commission's Rules of Practice and Procedure (18 CFR 385.214 or
385.211) and the Regulations under the NGA (18 CFR 157.10). A person
obtaining party status will be placed on the service list maintained by
the Secretary of the Commission and will receive copies of all
documents filed by the applicant and by all other parties. A party must
submit 14 copies of filings made with the Commission and must mail a
copy to the applicant and to every other party in the proceeding. Only
parties to the proceeding can ask for court review of Commission orders
in the proceeding.
    However, a person does not have to intervene in order to have
comments considered. The second way to participate is by filing with
the Secretary of the Commission, as soon as possible, an original and
two copies of comments in support of or in opposition to this project.
The Commission will consider these comments in determining the
appropriate action to be taken, but the filing of a comment alone will
not serve to make the filer a party to the proceeding. The Commission's
rules require that persons filing comments in opposition to the project
provide copies of their protests only to the party or parties directly
involved in the protest.
    The Commission strongly encourages electronic filings of comments,
protests and interventions in lieu of paper using the ``eFiling'' link
at http://www.ferc.gov. Persons unable to file electronically should
submit an original and 14 copies of the protest or intervention to the
Federal Energy regulatory Commission, 888 First Street, NE.,
Washington, DC 20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on May 14, 2009.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-9174 Filed 4-21-09; 8:45 am]

BILLING CODE 6717-01-P


I.   E.I. du Pont de Nemours and Company

PP No. 5F8435

EPA has received a pesticide petition PP No. 5F8435 from E.I. du Pont de
Nemours & Company (“DuPont”), 1007 Market Street, Wilmington, DE
19898, proposing pursuant to section 408 (d) of the Federal Food, Drug,
and Cosmetic Act, 21 U.S.C. 346a (d), to amend 40 CFR part 180 to
establish tolerances for residues of oxathiapiprolin,
1-(4-{4-[(5RS)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-t
hiazol-2-yl}-1-piperidyl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-y
l]ethanone in or on the following commodities: soybean at 0.01 ppm;
sunflower at 0.01 ppm.

EPA has determined that the petition contains data or information
regarding the elements set forth in section 408 (d) (2) of the FFDCA;
however, EPA has not fully evaluated the sufficiency of the submitted
data at this time or whether the data supports granting of the petition.
Additional data may be needed before EPA rules on the petition.

A. Residue Chemistry

1. Plant metabolism.  The metabolism of oxathiapiprolin is adequately
understood to support the proposed tolerances. Studies in grape, lettuce
and potato when treated at proposed label rates showed no significant
metabolites.  The metabolism of oxathiapiprolin in plants was similar
regardless of the crop or the treatment regime.  Oxathiapiprolin was the
principal residue in most crop fractions at various sampling points up
to crop maturity.  The overall metabolism of oxathiapiprolin in rotated
crops (cereals, root vegetables, leafy vegetables) was consistent with
metabolism seen in the primary crops.

2. Livestock Metabolism. The metabolism of oxathiapiprolin in ruminants
and poultry is adequately understood to support the proposed tolerances.
 Lactating goat and monogastric hen metabolism studies were conducted.
The metabolism of oxathiapiprolin in the rat was, in general, consistent
with that of the lactating goat (ruminant) and monogastric hen.

3. Analytical method.  Adequate analytical methodology, high-pressure
liquid chromatography with MS/MS detection, is available for enforcement
purposes.

4. Magnitude of residues. Field trials to meet country (Canada, the
United States) requirements were carried out at exaggerated rates in
soybeans and sunflowers.  The trials covered a range of locations,
climates and soil types and the data obtained represent a conservative
scenario for the commercial use of the oxathiapiprolin-containing
product in the major crop growing regions.

The oxathiapiprolin residues from these field trials were below the
limit of detection in all soybean and sunflower crop commodities.
Livestock feeding studies were not conducted.

B. Toxicological Profile

1. Acute toxicity. Based on EPA criteria, technical oxathiapiprolin is
classified as acute toxicology category IV based on overall results from
several studies. This compound is considered acute toxicology category
IV for acute oral, dermal and inhalation toxicity and eye and skin
irritation. Technical oxathiapiprolin is not a dermal sensitizer.

No evidence of neurotoxicity was observed in an acute study conducted
with oxathiapiprolin in rats. The no-observed-effect level (NOEL) and
no-observed-adverse-effect-level (NOAEL) in an acute neurotoxicity study
were 2000 mg oxathiapiprolin/kg bw, which was the highest dose
administered in the study.

2. Genotoxicty. Oxathiapiprolin was evaluated in a battery of in vitro
and in vivo genetic toxicology studies.  Negative results were obtained
in all studies indicating that oxathiapiprolin does not cause genetic
damage and, therefore, does not pose a mutagenic hazard.

3. Reproductive and developmental toxicity. No effects on fertility were
observed in one- and two-generation reproduction studies in rats.  No
effects on development were observed in developmental toxicity studies
in rats and rabbits. Slight delays in maturation were observed in male
rats in the reproduction studies, with a NOAEL of 104 mg/kg bw/day.  At
much higher doses, decreases in offspring body weight were also
observed.

4. Subchronic toxicity. Short-term oral feeding studies with
oxathiapiprolin were conducted in rats, mice and dogs with durations of
up to 90 days.  In addition, two other studies were performed in rats: a
14-day oral gavage study (conducted as a part of early discovery) and a
28-day dermal study. No adverse effects were observed in any of these
studies. In all cases, the NOAELs were greater than or equal to 1000
mg/kg bw/day. Non-adverse findings observed in these studies were
limited to changes in organ weights, clinical chemistry parameters and
liver cytochrome P450 isozymes.

Oxathiapiprolin showed no evidence of immunotoxicity in a 28-day feeding
study in mice.  Additionally, no indications of a potential for
oxathiapiprolin to affect the immune system were noted in the repeated
dose toxicity studies with rats, mice or dogs. Based on this,
oxathiapiprolin does not appear to pose an immunotoxic hazard.

Neurotoxicity endpoints were included in the subchronic (90-day feeding)
study that tested up to intake levels of >1000 mg/kg bw/day in male and
female rats. No evidence of neurotoxicity was observed.  No
treatment-related clinical signs indicative of potential neurotoxicity
were observed in repeated dose studies in mice or dogs.

5. Chronic toxicity. Based on the results of chronic feeding studies in
rats and mice, oxathiapiprolin was not carcinogenic in either species.
No indications of chronic toxicity were observed in either study.  A
one-year toxicity study was also conducted in dogs, with no
toxicologically relevant findings.  Possible test substance-related
changes in organ weights and clinical chemistry parameters were
observed.

6. Rat metabolism. [14C]Oxathiapiprolin was investigated in rats after
single low and high dose administration, and after multiple treatments
at low doses.  At the low dose (10 mg/kg bw) absorption was 31-49%, and
declined to 5.4-7.7% at the high dose (200 mg/kg bw).  Peak plasma
concentrations occurred at 0.25-9.5 hours.  Plasma 14C residue
concentrations showed steady-state kinetics in male and female rats
after multiple low dose administrations (10 mg/kg bw for 14 days).

Maximum tissue concentrations at Tmax occurred in the liver.  Clearance
was rapid for liver and other tissues by 168 hours after dosing.  All
tissues at 168 hours, including the carcass, collectively retained
<0.05% of the dose.  The pattern of distribution was similar between
sexes and single and multiple dose administration.  The low percentage
and concentration values in tissues indicate very low potential for
accumulation.

Plasma terminal elimination half-lives ranged from 40-51 hours following
single or multiple low-dose administration.  Excretion in urine and
faeces was >95% complete by 48 hours after single dosing.  The pattern
of excretion was similar after multiple dosing.  Faecal excretion was
the primary route of elimination ((90%).  Recovery in urine was much
lower ((2.5%).  Essentially no excretion occurred by exhalation.

Oxathiapiprolin metabolism pathways mainly involved hydroxylation at
various ring carbons and ring opening.  Pyrazole-piperidine bridge
cleavage followed by further oxidation resulted in pyrazole metabolites.

7. Metabolite toxicology. Oxathiapiprolin is considered to be the only
molecule of toxicological relevance.  Toxicology studies conducted with
metabolites support this conclusion.

8. Endocrine disruption. No relevant effects were observed on any
endocrine tissue in short- and long-term studies in rats, mice and dogs
to suggest an adverse impact on estrogen or androgen pathways or on
steroid biosynthesis.  The reproduction studies in rats provided
sufficient information to fully interpret the effects of oxathiapiprolin
on reproduction. No observations in that study suggested an adverse
effect on estrogen. Additionally, investigational studies were conducted
that suggest no adverse effects on estrogen. The slight delay in
maturation observed in male rats in the reproduction studies may be
exacerbated by weight effects; however, the data suggest that other
factors are involved. Investigational studies did not reveal any adverse
effects on androgens by oxathiapiprolin in rats.

C. Aggregate Exposure

The residue of concern is parent oxathiapiprolin only. Due to the
limited toxicity observed in the oxathiapiprolin toxicological database,
HED previously determined that toxicological endpoints and points of
departure (POD) were not required for oxathiapiprolin.

1. Dietary exposure

While dietary exposure to oxathiapiprolin may occur through food and
drinking water, no risks of concern are anticipated due to the lack of
toxicity at anticipated human exposure levels from the proposed new use
for oxathiapiprolin as a seed treatment for soybean and sunflower seed.

2. Non-dietary exposure. Since there are no residential or home uses
non-dietary exposure has not been assessed.

D. Cumulative Effects

A determination has not been made that oxathiapiprolin has a common
mechanism of toxicity with other substances. Oxathiapiprolin does not
appear to produce a common toxic metabolite with other substances. A
cumulative risk assessment was, therefore, not performed for this
analysis.

E. Safety Determination

1. U.S. population. While dietary exposure to oxathiapiprolin may occur
through food and drinking water, no risks of concern are anticipated due
to the lack of toxicity at anticipated human exposure levels from the
proposed new use for oxathiapiprolin as a seed treatment for soybean and
sunflower seed. Thus, there is a reasonable certainty that no harm will
result to the general population from the aggregate exposure to
oxathiapiprolin.  No additional safety factors are warranted.

2. Infants and children. While dietary exposure to oxathiapiprolin may
occur through food and drinking water, no risks of concern are
anticipated due to the lack of toxicity at anticipated human exposure
levels from the proposed new use for oxathiapiprolin as a seed treatment
for soybean and sunflower seed. Thus, there is a reasonable certainty
that no harm will result to infants and children from the aggregate
exposure to oxathiapiprolin.  No additional safety factors are
warranted.

F. INTERNATIONAL TOLERANCES

No tolerances have been established to date for oxathiapiprolin on
soybean or sunflower.

Pesticide Petition to Establish Tolerances for Oxathiapiprolin


[Federal Register Volume 86, Number 220 (Thursday, November 18, 2021)]
[Notices]
[Pages 64467-64468]
[FR Doc No: 2021-25179]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP20-48-000]

Iroquois Gas Transmission System, L.P.; Notice of Availability of
The Final Environmental Impact Statement for The Proposed Enhancement
by Compression Project

    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) has prepared a final environmental impact statement (EIS)
for the Enhancement by Compression Project (Project), proposed by
Iroquois Gas Transmission System, L.P. (Iroquois) in the above-
referenced docket. Iroquois requests authorization to construct and
operate natural gas transmission facilities in New York and
Connecticut. The Project is designed to provide a total of 125,000
dekatherms per day of incremental firm transportation service for two
existing customers of Iroquois, Consolidated Edison Company of New
York, Inc. and KeySpan Gas East Corporation doing business as National
Grid.
    The final EIS assesses the potential environmental effects of the
construction and operation of the Project in accordance with the
requirements of the National Environmental Policy Act. The final EIS is
not a decision document. It presents Commission staff's independent
analysis of the environmental issues for the Commission to consider
when addressing the merits of all issues in this proceeding.
    The final EIS responds to comments that were received on the
Commission's September 30, 2020 Environmental Assessment (EA) and June
11, 2021 draft EIS \1\ and discloses downstream greenhouse gas
emissions for the Project. With the exception of climate change
impacts, FERC staff concludes that approval of the proposed Project,
with the mitigation measures recommended in this EIS, would not result
in significant environmental impacts. FERC staff continues to be unable
to determine significance with regards to climate change impacts.
---------------------------------------------------------------------------

    \1\ The Project's Environmental Assessment is available on
eLibrary under accession no. 20200930-3011 and the draft EIS is
available under accession no. 20210611-3022.
---------------------------------------------------------------------------

    The final EIS incorporates the above-referenced EA, which addressed
the potential environmental effects of the construction and operation
of the following Project facilities:
     Athens Compressor Station--installation of one new 12,000
horsepower (hp) natural gas-fired turbine (Unit A2) in a new building
with associated cooling, filter separators, and other facilities
connecting to Iroquois' existing 24-inch-diameter mainline within the
existing fenced compressor station boundary (Greene County, New York).
     Dover Compressor Station--installation of one new 12,000
hp natural gas-fired turbine (Unit A2) in a new building with
associated cooling, filter separators, and other facilities connecting
to Iroquois' existing 24-inch-diameter mainline and expansion of the
existing compressor station fenceline within the property boundary
(Dutchess County, New York).
     Brookfield Compressor Station--construction of a control/
office building, addition of two new 12,000 hp, natural gas-fired
turbines (Unit B1 and Unit B2) in a new building with associated
cooling, filter separators, and other typical facilities connecting to
Iroquois' existing 24-inch-diameter mainline. Additionally, Iroquois
would install incremental cooling at Plant 2-A to allow for compressed
discharge gas to be cooled, prior to being compressed at the proposed
downstream compressors (Units B1 and B2). Iroquois would also replace
existing turbine stacks on the existing compressor units (Unit-A1 and
Unit-A2) and add other noise reduction measures (e.g., louvers, seals)
to minimize existing noise at the site. Modifications at this site
would require expansion of the existing compressor station fenceline
within the property boundary (Fairfield County, Connecticut).
     Milford Compressor Station--addition of gas cooling to
existing compressor units and associated piping to allow for compressed
discharge gas to be cooled within the current fenced boundaries of the
existing compressor station, where no gas cooling facilities currently
exist (New Haven County, Connecticut).
    The Commission mailed a copy of the Notice of Availability of the
Final Environmental Impact Statement for the Proposed Enhancement by
Compression Project to federal, state, and local government
representatives and agencies; elected officials; environmental and
public interest groups; Native American Tribes; potentially affected
landowners and other interested individuals and groups; and newspapers
and libraries in the Project area. The final EIS is only available in
electronic format. It may be viewed and downloaded from the FERC's
website (www.ferc.gov), on the natural gas environmental documents page
(https://www.ferc.gov/industries-data/natural-gas/environment/environmental-documents). In addition, the final EIS may be accessed by
using the eLibrary link on the FERC's website. Click on the eLibrary
link (https://elibrary.ferc.gov/eLibrary/search) select ``General
Search'' and enter the docket number in the ``Docket Number'' field
(i.e., CP20-48-000). Be sure you have selected an appropriate date
range. For assistance, please contact FERC Online Support at
[email protected] or toll free at<PHONE_NUMBER>, or for TTY,
contact<PHONE_NUMBER>.
    Additional information about the Project is available from the
Commission's Office of External Affairs, at (866) 208-FERC, or on the
FERC website (www.ferc.gov) using the eLibrary link. The eLibrary link
also

provides access to the texts of all formal documents issued by the
Commission, such as orders, notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription that allows you to keep track of all formal issuances and
submittals in specific dockets. This can reduce the amount of time you
spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. Go to https://www.ferc.gov/ferc-online/overview to
register for eSubscription.

    Dated: November 12, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021-25179 Filed 11-17-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 200 (Thursday, October 16, 2014)]
[Notices]
[Pages 62237-62239]
[FR Doc No: 2014-24541]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-73327; File No. SR-CBOE-2014-072]

Self-Regulatory Organizations; Chicago Board Options Exchange,
Incorporated; Notice of Filing and Immediate Effectiveness of a
Proposed Rule Change To Amend the Fees Schedule

October 9, 2014.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that on October 1, 2014, Chicago Board Options Exchange, Incorporated
(the ``Exchange'' or ``CBOE'') filed with the Securities and Exchange
Commission (the ``Commission'') the proposed rule change as described
in Items I, II, and III below, which Items have been prepared by the
Exchange. The Commission is publishing this notice to solicit comments
on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend its Fees Schedule. The text of the
proposed rule change is available on the Exchange's Web site (http://www.cboe.com/AboutCBOE/CBOELegalRegulatoryHome.aspx), at the Exchange's
Office of the Secretary, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of

the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to amend its Fees Schedule, to be effective
October 1, 2014. Specifically, the Exchange proposes to increase the
Customer Priority Surcharge fee assessed to contracts executed in VIX
volatility index options (``VIX options''). Currently, the VIX Customer
Priority Surcharge (``Surcharge'') is assessed on all Customer (C) VIX
contracts executed electronically that are Maker and not Market Turner.
Additionally, the surcharge is only assessed on such contracts that
have a premium of $0.11 or greater. The Exchange proposes to increase
the Surcharge from $0.05 per contract to $0.10 per contract on such
contracts that have a premium of $0.11 or greater.
2. Statutory Basis
    The Exchange believes the proposed rule change is consistent with
the Securities Exchange Act of 1934 (the ``Act'') and the rules and
regulations thereunder applicable to the Exchange and, in particular,
the requirements of Section 6(b) of the Act.\3\ Specifically, the
Exchange believes the proposed rule change is consistent with the
Section 6(b)(5) \4\ requirements that the rules of an exchange be
designed to prevent fraudulent and manipulative acts and practices, to
promote just and equitable principles of trade, to foster cooperation
and coordination with persons engaged in regulating, clearing,
settling, processing information with respect to, and facilitation
transactions in securities, to remove impediments to and perfect the
mechanism of a free and open market and a national market system, and,
in general, to protect investors and the public interest. The Exchange
also believes the proposed rule change is consistent with Section
6(b)(4) of the Act,\5\ which provides that Exchange rules may provide
for the equitable allocation of reasonable dues, fees, and other
charges among its Trading Permit Holders.
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78f(b).
    \4\ 15 U.S.C. 78f(b)(5).
    \5\ 15 U.S.C. 78f(b)(4).
---------------------------------------------------------------------------

    The Exchange believes that the VIX Customer Priority Surcharge
increase is reasonable because the amount of the new fee is within the
range of surcharges assessed for customer transactions in other CBOE
proprietary products (for example customers are currently assessed a
$0.20 Hybrid 3.0 Execution Surcharge (which essentially acts as a
customer priority surcharge) in SPX options).
    The Exchange believes that it is equitable and not unfairly
discriminatory to assess the VIX Priority Surcharge to Customers and
not other market participants because Customers are not subject to
additional costs for effecting transactions in VIX which are applicable
to other market participants, such as license surcharges. Additionally,
Customers are not subject to fees applicable to other market
participants such as connectivity fees and fees relating to Trading
Permits, and are not subject to the same obligations as other market
participants, including regulatory and compliance requirements and
quoting obligations. The Exchange believes that it is equitable and not
unfairly discriminatory to only assess the Surcharge to Maker Non-
Turners because the Exchange wants to encourage improving the market
(``turning'').
    The Exchange believes that it is equitable and not unfairly
discriminatory to only assess this fee when the contract premium is at
least $0.11 because the Exchange wants to reduce costs on low priced
VIX options to encourage Customers to close and roll over positions
close to expiration at low premium levels. Currently, such Customers
are less likely to do this because the transaction fee is closer to the
premium level. The Exchange believes that maintaining lowered fees
overall for VIX options trading with a premium of $0.00-$0.10 will
encourage the trading of such options. As such, the Exchange does not
wish to assess Customer Priority Surcharge on such options in order to
keep the costs low.
    The Exchange believes that increasing the customer priority
surcharge for VIX options and not VXST is equitable and not unfairly
discriminatory because VXST is a relatively new product that the
Exchange has expended significant resources in developing and believes
that not assessing a higher surcharge will encourage trading in VXST.

B. Self-Regulatory Organization's Statement on Burden on Competition

    CBOE does not believe that the proposed rule change will impose any
burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act because, while different
electronic transaction fees are assessed to different market
participants, different market participants have different obligations
and circumstances as noted above. The Exchange believes that the
proposal to increase the surcharge amount assessed to Customers for
executions in VIX contracts will not cause an unnecessary burden on
intermarket competition because the proposed change was not motivated
by intermarket competition. Additionally, VIX is only traded on CBOE.
To the extent that the proposed changes make CBOE a more attractive
marketplace for market participants at other exchanges, such market
participants are welcome to become CBOE market participants.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The Exchange neither solicited nor received comments on the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change has become effective pursuant to Section
19(b)(3)(A) of the Act \6\ and paragraph (f) of Rule 19b-4 \7\
thereunder. At any time within 60 days of the filing of the proposed
rule change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission will institute proceedings to
determine whether the proposed rule change should be approved or
disapproved.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78s(b)(3)(A).
    \7\ 17 CFR 240.19b-4(f).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-CBOE-2014-072 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-CBOE-2014-072. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549 on official business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the filing also will be available
for inspection and copying at the principal office of the Exchange. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-CBOE-2014-072 and should be
submitted on or before November 6, 2014.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\8\
---------------------------------------------------------------------------

    \8\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2014-24541 Filed 10-15-14; 8:45 am]
BILLING CODE 8011-01-P